Silybin-vitamin E-phospholipids complex reduces liver fibrosis in patients with chronic hepatitis C treated with pegylated interferon α and ribavirin

Chronic hepatitis C is both a virologic and a fibrotic disease, with mortality resulting mainly from the complications of cirrhosis and HCC. The aim was to evaluate the impact on of supplementation with a new pharmaceutical complex of silybinvitamin E-phospholipids in patients with chronic hepatitis...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Am J Transl Res
Glavni autori: Malaguarnera, Michele, Motta, Massimo, Vacante, Marco, Malaguarnera, Giulia, Caraci, Filippo, Nunnari, Giuseppe, Gagliano, Caterina, Greco, Carmela, Chisari, Giuseppe, Drago, Filippo, Bertino, Gaetano
Format: Artigo
Jezik:Inglês
Izdano: e-Century Publishing Corporation 2015
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4697727/
https://ncbi.nlm.nih.gov/pubmed/26807195
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items